The effect of comorbidity severity on pulmonary rehabilitation outcomes in chronic obstructive pulmonary disease patients

Chronic Respiratory Disease

Volumn 16, Issue , 2018, Pages

  Naz, Ilknur ^a   Sahin, Hulya ^b   Varol, Yelda ^b   Kömürcüoğlu, Berna ^b  

^a IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^b Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital   (Turkey)

Author keywords

Charlson Comorbidity Index; Chronic obstructive pulmonary disease; comorbidity; pulmonary rehabilitation

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BODY MASS; BODY PLETHYSMOGRAPHY; BREATHING EXERCISE; CHARLSON COMORBIDITY INDEX; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH PROGRAM; HEART RATE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITALIZATION; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULMONARY REHABILITATION; PULSE OXIMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; SHORT FORM 36; SIX MINUTE WALK TEST; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; FOLLOW UP; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TURKEY (BIRD);

AGED; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TURKEY;

EID: 85056633743     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972318809472     Document Type: Article

References (31)

1. Boutou AK, Shrikrishna D, Tanner RJ. Lung function indices for predicting mortality in COPD. Eur Respir J 2013; 42: 616–625
2. Hill K, Vogiatzis I, Burtin C. The importance of components of pulmonary rehabilitation, other than exercise training, in COPD. Eur Respir Rev 2013; 22: 405–413
3. Carreiro A, Santos J, Rodrigues F. Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease. Rev Port Pneumol 2013; 9: 106–113
4. Crisafulli E, Costi S, Luppi F. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 2008; 63: 487–492
5. Nici L, Donner C, Wouters E. ATS/ERS pulmonary rehabilitation writing committee. American thoracic society/European respiratory society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390–1413
6. Nici L, Zuwallack R. Scope, background and definition of pulmonary rehabilitation. Eur J Phys Rehabil Med 2011; 47: 465–474
7. Spruit MA, Singh SJ, Garvey C. ATS/ERS task force on pulmonary rehabilitation. An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13–e64
8. Maged H, Sahar M, Nashwa HAW. Effect of comorbidities on response to pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Egypt J Chest Diseas Tubercul 2016; 65: 63–69
9. Franssen FME, Rochester CL. Comorbidities in patients with COPD and pulmonary rehabilitation: Do they matter? Eur Respir Rev 2014; 23: 131–141
10. Hornikx M, Van Remoortel H, Demeyer H. The influence of comorbidities on outcomes of pulmonary rehabilitation programs in patients with COPD: a systematic review. Biomed Res Int 2013; 2013: 146–148
11. Quanjer PH, Tammeling GJ, Cotes JE. Lung volumes and forced ventilatory flows. Work group on standardization of respiratory function tests. European Community for Coal and Steel. Official position of the European Respiratory Society. Rev Mal Respir 1994; 11: 5–40
12. GOLD executive committee. Global strategy for diagnosis, management and prevention of COPD, http://www.goldcopd.com (updated 2009; accessed 2010 July 1)
13. Tunsupon P, Lal A, Khamis MA. Comorbidities in patients with chronic obstructive pulmonary disease and pulmonary rehabilitation outcomes. J Cardiopulm Rehabil Prev 2017; 37(4): 283–289
14. Beddhu S, Bruns FJ, Saul M. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000; 108(8): 609–613
15. Marti S, Munoz X, Rios J. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27: 689–696
16. Echave-Sustaeta JM, Casanova LC, Cosio BG. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? International Journal of COPD 2014; 9: 1307
17. Miller MR, Crapo R, Hankinson J,; ATS/ERS task force. General considerations for lung function testing. Eur Respir J 2005; 26: 153–161
18. Sweer L, Zwillich CW. Dyspnea in the patient with chronic obstructive pulmonary disease. Etiology and management. Clin Chest Med 1990; 11: 417–445
19. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117
20. Polatlı M, Yorgancıoğlu A, Aydemir Ö. Validity and reliability of Turkish version of St. George’s respiratory questionnaire. Tuberk Toraks 2013; 61: 81–87
21. Koçyiğit H, Aydemir Ö, Fişek G. Validity and reliability of Turkish version of Short Form SF-36. Turkish J Drugs Therapeutics 1999; 12: 102–106
22. Luxton N, Alison JA, Wu J. Relationship between field walking tests and incremental cycle ergometry in COPD. Respirology 2008; 13: 856–862
23. Hassan M, Mourad S, Wahab NHA. Effect of comorbidities on response to pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Egypt J Chest Diseases Tubercul 2016; 65(1): 63–69
24. Higashimoto Y, Yamagata T, Maeda K. Influence of comorbidities on the efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int 2016; 16(8): 934–941
25. Charlson ME, Pompei P, Ales KL. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–383
26. Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5: 647–662
27. Brown JP, Martinez CH. Chronic obstructive pulmonary disease comorbidities. Curr Opin Pulm Med 2016; 22: 113–118
28. Dal Negro RW, Bonadiman L, Turco P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med 2015; 10: 24
29. Crisafulli E, Gorgone P, Vagaggini B. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J 2010; 36: 1042–1048
30. Shebl A, Fadila D. Impact of pulmonary rehabilitation program on health outcomes of patients with chronic obstructive pulmonary disease. J Educat Pract 2013; 4: 78–86
31. Cavaillès A, Brinchault-Rabin G, Dixmier A. Comorbidities of COPD. Eur Respir Rev 2013; 22: 454–475